Begin main content

Reports

We found 4707 result(s)

Emerging Technology List — Endoscopic suturing system

Published on: January 27, 2002
Result type: Reports
Product Line: Emerging Technology List

Tags

Gastroesophageal Reflux, Heartburn, Pyrosis, Esophagogastric Junction, Endoscopy, Digestive System, Digestive System Endoscopic Surgical Procedures, Minimally Invasive Surgical Procedures, Suture Techniques, Gastroscopy, Equipment and Supplies, Device Approval, GERD, Gastrointestinal Tract, Endoscopy, Digestive System, Surgical Procedures, Minimally Invasive, Digestive system, Medical Devices, Gastrointestinal tract, Reflux gastrooesophagien, Jonction Oesophagogastrique, Esophageal Sphincter, Endoscopie digestive, Surgical Procedures, Minimally Invasive, Chirurgie peu invasive, Techniques Suture, Gastroscopie, Équipement et appareillage, Medical equipment, Autorisation, mise sur marché matériel, Regulatory status, EndoCinch, RGOP, Interventions endoscopiques appareil digestif, Chirurgies effraction minimale, Équipement médical, Dispositifs médicaux, Réglementation

The efficacy of proton pump inhibitors in adults with functional dyspepsia

Published on: January 19, 2002
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: Shiau JY, Shukla VK, Dubé C. The Efficacy of Proton Pump Inhibitors in Adults with Functional Dyspepsia. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2002. Technology report no 22. Background Functional dyspepsia refers to discomfort centred in the upper abdomen with no biochemical or organic cause (in...

Tags

Proton Pump Inhibitors, Omeprazole, Dyspepsia, Meta-Analysis, Gastrointestinal Tract, Gastrointestinal tract, Proton Pumps - antagonists & inhibitors, PPI, lansoprazole, pantoprazole, functional dyspepsia, Pompe à protons – antagonistes et inhibiteurs, Inhibiteurs de la pompe à protons, IPP, Lansoprazole, Pantoprazole, Dyspepsie, dyspepsie fonctionnelle, méta-analyse

The new fluoroquinolones in community-acquired pneumonia: Clinical and economic perspectives

Published on: December 21, 2001
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

Cite as: Metge CJ, Vercaigne LM, Carrie A, Sarveiya V, Zhanel GG. The new fluoroquinolones in community-acquired pneumonia: clinical and economic perspectives. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2001. Technology Overview no 5. The Issue The increasing resistance to currently available antibiotics requ...

Tags

Quinolones, Anti-Infective Agents, Fluoroquinolones, Community-Acquired Infections, Pneumonia, Drug Resistance, Cross Infection, Bacterial Infections, Canada, Antiinfective Agents, Infection, Hospital Infections, Nosocomial Infections, Bacterial Infection, Infections, Hospital, Infections, Nosocomial, Drug Resistance, Microbial, Infections, Community-Acquired, Pneumonia, pneumonie, quinolone, Fluoroquinolone, Microbial, Agents, Anti-Infective, Anti-infective, Anti Infective Agents, Infections, Community-Acquired, Community Acquired Infections, Community-Acquired Infection, Community Acquired, Drug Resistances, Resistance, Drug, Resistances, Cross, Hospital, Nosocomial, Cross Infections, Hospital Infection, Bacterial, Infection Bacterial, Antiinfectieux, Infection Acquise Communaute, Resistance Aux Medicaments, Infection Hospitaliere, Infections bacterienne

Do neuraminidase inhibitors prevent influenza?

Published on: December 15, 2001
Result type: Reports

Summary Two neuraminidase inhibitors, zanamivir and oseltamivir, are well-tolerated and reduce the likelihood of contracting influenza in both healthy individuals and those who are at risk for developing complications. There is insufficient evidence to conclude that neuraminidase inhibitors reduce complications, hospitalization and death from la...

Tags

Neuraminidase, Influenza, Influenza, flu, Neuraminidase Inhibitors

Oseltamivir for the treatment of suspected influenza: A clinical and economic assessment

Published on: December 14, 2001
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: Husereau DR, Brady B, McGeer A. Oseltamivir for the Treatment of Suspected Influenza: A Clinical and Economic Assessment. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2001. Technology report no 21. The Issue Annually, influenza causes significant morbidity and mortality. Mortality occurs primarily in t...

Tags

Oseltamivir, Tamiflu, Influenza, Grippe, Drug Therapy, Cost-Benefit Analysis, Influenza, Neuraminidase inhibitors, flu, Chimiothérapie, Analyse coût bénéfice, Cost-effectiveness analysis, Economic evaluation, inhibiteurs de la neuraminidase, analyse coût-efficacité, évaluation économique

New fluoroquinolones in community-acquired pneumonia: A clinical and economic evaluation

Published on: December 5, 2001
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: Metge CJ, Vercaigne LM, Carrie A, Sarveiya V, Zhanel GG. The new fluoroquinolones in community-acquired pneumonia: clinical and economic perspectives. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2001. Technology report no 20. Objectives: To critically review and compare, both clinically and economical...

Tags

Quinolones, Fluoroquinolones, Antiinfective Agents, Infection, Pneumonia, Nosocomial Infections, Bacterial Infection, Bacterial Infections, Infections, Hospital, Infections, Nosocomial, Infections, Community-Acquired, Pneumonia, Agents, Anti-Infective, Anti-infective, Anti Infective Agents, Infections, Community-Acquired, Community Acquired Infections, Community-Acquired Infection, Community Acquired, Drug Resistances, Resistance, Drug, Resistances, Drug Hospital Infections, Cross, Hospital, Nosocomial, Cross Infections, Hospital Infection, Bacterial, Infection Bacterial

Emerging Technology List — Given® diagnostic imaging system

Published on: November 30, 2001
Result type: Reports
Product Line: Emerging Technology List

Tags

Capsule Endoscopy, Endoscopy, Video Recording, Miniaturization, Small Intestine, Diagnostic Tests, Diagnostic tests, Imaging, Imaging capsule, Imaging pill, M2A, Given diagnostic imaging system, imaging capsule, Gastrointestinal, Given, Video camera, Système imagerie diagnostique Given, Intestin grêle, Caméra vidéo, Équipement médical, Dispositifs médicaux, Stade réglementation

Vagus nerve stimulation (VNS) for treatment-resistant depression

Published on: November 28, 2001
Result type: Reports

Summary Vagus nerve stimulation, originally used to reduce seizures in epilepsy patients, is now under investigation for treatment-resistant depression. A device used for vagus nerve stimulation, the NeuroCybernetic Prosthesis (NCP®) System, recently received Health Canada approval for use in treatment-resistant depression. It is still considere...

Tags

Depressive Disorder, Electric Stimulation Therapy, Electroconvulsive Therapy, Vagus Nerve, Recurrence, Prostheses and Implants, Equipment and Supplies, Costs and Cost Analysis, Technology Assessment, Canada, Depression, Electroshock, Relapse, Depression, Medical Devices, Biomedical, EST, Vagus nerve stimulator, VNS, NeuroCybernetic Prosthesis, NCP System, Medical equipment, Health technology assessment, HTA, Trouble dépressif, Électrothérapie, Thérapie convulsivante à l’électrochoc, Nerf Pneumogastrique, Récidive, Prothèses et implants, Équipement et appareillage, Coût et analyse coûts, Évaluation technologie biomédicale, Électrochoc, Stimulateur du nerf vague, SNV, Système NCP, Rechute, Équipement médical, Dispositifs médicaux, Évaluation des technologies de la santé, ETS

Transdermal contraceptive patch - A new birth control option

Published on: November 28, 2001
Result type: Reports

Summary A new, once-weekly contraceptive patch (Ortho Evra™) that delivers transdermally norelgestromin and ethinyl estradiol was approved by the U.S. FDA November, 2001. Patch drug delivery systems theoretically offer advantages over oral therapy, including enhanced adherence to treatment regimen and reduction in adverse events. A randomized co...

Tags

Birth Control, Transdermal Administration, Contraception, Gynecology/obstetrics, Transdermal, Contraceptive Patch, Patch, Contraceptive

The challenges of early assessment: Leukotriene receptor antagonists

Published on: November 19, 2001
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Cite as: Schachter HM, Kovesi T, Ducharme F, Langford S, Clifford T, Moher D. The challenges of early assessment: leukotriene receptor antagonists. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 2001. Technology report no 19. The two leukotriene receptor antagonists (LTRAs) montelukast and zafirlukast have been m...

Tags

Asthma, Drug Therapy, Leukotriene Antagonists, Budesonide, Beclometasone, Triamcinolone, Research Design, Bias (Epidemiology), Data Quality, Publication Bias, Asthma, Asthme, Chimiothérapie, Antagonistes leucotriènes, Antileukotrienes, Antileucotriènes, ALTs, ALT, ATRAs, Acides rétinoïques, Anti-Asthmatic, Agents Antiasthmatiques, Inhaled glucocorticoids, Glucocorticoïdes inhalés, Inhaled corticosteroids, Glucocorticostéroïdes inhalés, Budesonide Beclomethasone, acetonide Triamcinolone acetonide, zafirlukast, montelukast, montélukast, flunisolide, fluticasone, Projet recherche, Biais (épidémiologie), Qualité des données, Biais publication, Grey Literature, Documentation grise, Gray Literature, Clinical Trials, Essai clinique, Systematic reviews, Examens systématiques, Qualitative reviews, Examens qualitatifs Documentation grise, Examens qualitatifs